Comparison of high-dimensional confounder summary scores in comparative studies of newly marketed medications.


OBJECTIVE To compare confounding adjustment by high-dimensional propensity scores (hdPSs) and historically developed high-dimensional disease risk scores (hdDRSs) in three comparative study examples of newly marketed medications: (1) dabigatran vs. warfarin on major hemorrhage; (2) on death; and (3) cyclooxygenase-2 inhibitors vs. nonselective nonsteroidal… (More)
DOI: 10.1016/j.jclinepi.2016.02.011


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics